These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30830742)

  • 1. Toward Single-Peak Dalbavancin Analogs through Biology and Chemistry.
    Alt S; Bernasconi A; Sosio M; Brunati C; Donadio S; Maffioli SI
    ACS Chem Biol; 2019 Mar; 14(3):356-360. PubMed ID: 30830742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mechanism of glycopeptide resistance in the A40926 producer Nonomuraea sp. ATCC 39727.
    Marcone GL; Beltrametti F; Binda E; Carrano L; Foulston L; Hesketh A; Bibb M; Marinelli F
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2465-72. PubMed ID: 20308385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved production of A40926 by Nonomuraea sp. through deletion of a pathway-specific acetyltransferase.
    Sosio M; Canavesi A; Stinchi S; Donadio S
    Appl Microbiol Biotechnol; 2010 Aug; 87(5):1633-8. PubMed ID: 20414653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic-Led Discovery of a Novel Glycopeptide Antibiotic by
    Yushchuk O; Vior NM; Andreo-Vidal A; Berini F; Rückert C; Busche T; Binda E; Kalinowski J; Truman AW; Marinelli F
    ACS Chem Biol; 2021 May; 16(5):915-928. PubMed ID: 33913701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding and manipulating glycopeptide pathways: the example of the dalbavancin precursor A40926.
    Sosio M; Donadio S
    J Ind Microbiol Biotechnol; 2006 Jul; 33(7):569-76. PubMed ID: 16761167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two Master Switch Regulators Trigger A40926 Biosynthesis in Nonomuraea sp. Strain ATCC 39727.
    Lo Grasso L; Maffioli S; Sosio M; Bibb M; Puglia AM; Alduina R
    J Bacteriol; 2015 Aug; 197(15):2536-44. PubMed ID: 25986904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by nonomuraea species.
    Sosio M; Stinchi S; Beltrametti F; Lazzarini A; Donadio S
    Chem Biol; 2003 Jun; 10(6):541-9. PubMed ID: 12837387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-yield production of lipoglycopeptide antibiotic A40926 using a mutant strain Nonomuraea sp. DP-13 in optimized medium.
    Chen M; Xu T; Zhang G; Zhao J; Gao Z; Zhang C
    Prep Biochem Biotechnol; 2016; 46(2):171-5. PubMed ID: 25831044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and characterization of monochlorinated and dechlorinated A40926 derivatives.
    Beltrametti F; Lazzarini A; Brunati C; Marazzi A; Jovetic S; Selva E; Marinelli F
    J Antibiot (Tokyo); 2003 Sep; 56(9):773-82. PubMed ID: 14632287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A derivative of the glycopeptide A40926 produced by inactivation of the beta-hydroxylase gene in Nonomuraea sp. ATCC39727.
    Stinchi S; Carrano L; Lazzarini A; Feroggio M; Grigoletto A; Sosio M; Donadio S
    FEMS Microbiol Lett; 2006 Mar; 256(2):229-35. PubMed ID: 16499611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Origin, structure, and activity in vitro and in vivo of dalbavancin.
    Malabarba A; Goldstein BP
    J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii15-20. PubMed ID: 15750032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides.
    Maffioli SI; Ciabatti R; Romanò G; Marzorati E; Preobrazhenskaya M; Pavlov A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3801-5. PubMed ID: 15993054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gene transfer system for the glycopeptide producer Nonomuraea sp. ATCC39727.
    Stinchi S; Azimonti S; Donadio S; Sosio M
    FEMS Microbiol Lett; 2003 Aug; 225(1):53-7. PubMed ID: 12900021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformations of lipoglycopeptides to obtain novel antibiotics.
    Gandolfi R; Jovetic S; Marinelli F; Molinari F
    J Antibiot (Tokyo); 2007 Apr; 60(4):265-71. PubMed ID: 17456978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycopeptide antibiotics: from conventional molecules to new derivatives.
    Van Bambeke F; Van Laethem Y; Courvalin P; Tulkens PM
    Drugs; 2004; 64(9):913-36. PubMed ID: 15101783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between glycopeptide production and resistance in the actinomycete Nonomuraea sp. ATCC 39727.
    Marcone GL; Binda E; Carrano L; Bibb M; Marinelli F
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5191-201. PubMed ID: 24957828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex Regulatory Networks Governing Production of the Glycopeptide A40926.
    Alduina R; Sosio M; Donadio S
    Antibiotics (Basel); 2018 Apr; 7(2):. PubMed ID: 29621136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate-controlled regulator for the biosynthesis of the dalbavancin precursor A40926.
    Alduina R; Lo Piccolo L; D'Alia D; Ferraro C; Gunnarsson N; Donadio S; Puglia AM
    J Bacteriol; 2007 Nov; 189(22):8120-9. PubMed ID: 17873036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dalbavancin: a new option for the treatment of gram-positive infections.
    Lin SW; Carver PL; DePestel DD
    Ann Pharmacother; 2006 Mar; 40(3):449-60. PubMed ID: 16507624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production enhancement of the glycopeptide antibiotic A40926 by an engineered Nonomuraea gerenzanensis strain.
    Yan B; Gao W; Tian L; Wang S; Dong H
    Biotechnol Lett; 2022 Feb; 44(2):259-269. PubMed ID: 34826003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.